Medical technology firm Ceretas is advancing its initial public offering to the Australian Securities Exchange, with owners targeting a listing as early as the end of this week.
The accelerated timeline follows strong demand for the offering, prompting the company to move up from its originally scheduled July 28 debut date.
The University of Queensland spin-out, which specializes in portable ultrasound devices, is using the capital raise to fund ongoing clinical trials.
The fast-track listing reflects a broader trend of companies seeking to capitalize on favorable market conditions and investor interest in healthcare innovation.
By shortening the window between pricing and listing, Ceretas aims to maintain momentum and secure funding for its development pipeline more quickly.
The move comes as global equity markets have seen renewed activity, with several firms accelerating their public debuts to take advantage of improved sentiment.